标题
Incretin physiology and pathophysiology from an Asian perspective
作者
关键词
-
出版物
Journal of Diabetes Investigation
Volume 6, Issue 5, Pages 495-507
出版商
Wiley
发表日期
2014-11-03
DOI
10.1111/jdi.12305
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
- (2014) Abhishek S. Chitnis et al. ADVANCES IN THERAPY
- Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young--Type 2 and Type 3
- (2014) S. H. Ostoft et al. DIABETES
- Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants
- (2014) Uduakobong E. Ntuk et al. DIABETES CARE
- Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis
- (2014) Y. G. Kim et al. DIABETES OBESITY & METABOLISM
- Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin
- (2014) Heike Zimdahl et al. DIABETOLOGIA
- Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
- (2014) Daniela Jakubowicz et al. DIABETOLOGIA
- Acute Pancreatitis in Patients with Type 2 Diabetes Mellitus Treated with Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Nested Case-Control Study
- (2014) Hsin-Chun Chou et al. DRUG SAFETY
- Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
- (2014) Amy G. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Incretin Response After Successful Islet Transplantation
- (2014) Shireene R. Vethakkan et al. TRANSPLANTATION
- Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
- (2014) Daisuke Yabe et al. Journal of Diabetes Investigation
- Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
- (2013) Young Min Cho et al. Annual Review of Physiology
- The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes
- (2013) Tae Jung Oh et al. CLINICAL ENDOCRINOLOGY
- The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
- (2013) Leen M. ‘t Hart et al. DIABETES
- Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians
- (2013) Jonas B. Møller et al. DIABETES CARE
- Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response: A systematic review and meta-analysis
- (2013) K. Kodama et al. DIABETES CARE
- Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes: Systematic review and meta-analysis of clinical studies
- (2013) S. Calanna et al. DIABETES CARE
- Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
- (2013) S. Calanna et al. DIABETOLOGIA
- Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
- (2013) Y. G. Kim et al. DIABETOLOGIA
- CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
- (2013) Sang Ah Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus
- (2013) M. Kosinski et al. REGULATORY PEPTIDES
- Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas
- (2013) Yutaka Seino et al. Journal of Diabetes Investigation
- Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis
- (2012) Haesuk Park et al. ANNALS OF PHARMACOTHERAPY
- Potential correlation between plasma total GIP levels and body mass index in Japanese patients with types 1 or 2 diabetes mellitus
- (2012) Kyuzi Kamoi et al. ENDOCRINE JOURNAL
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- Targeting the glucagon receptor family for diabetes and obesity therapy
- (2012) Young Min Cho et al. PHARMACOLOGY & THERAPEUTICS
- Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations
- (2012) Takafumi Senmaru et al. Journal of Diabetes Investigation
- Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels
- (2012) Masahiro Iwasaki et al. Journal of Diabetes Investigation
- Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
- (2011) J. J. Holst et al. DIABETES CARE
- Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes
- (2011) Takashi Nomiyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
- (2011) Jonatan I. Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea
- (2011) Yoshimasa Aso et al. Translational Research
- Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
- (2011) Daisuke Yabe et al. Journal of Diabetes Investigation
- Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in Type 2 Diabetes in a Chinese population
- (2010) Xueyao Han et al. BMC Medical Genetics
- Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired -Cell Function?
- (2010) J. J. Meier et al. DIABETES
- Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study
- (2010) A. Sathananthan et al. DIABETES CARE
- Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes
- (2010) Seung Jin Han et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes
- (2010) Soushou LEE et al. ENDOCRINE JOURNAL
- Six major steps in animal evolution: are we derived sponge larvae?
- (2010) Claus Nielsen EVOLUTION & DEVELOPMENT
- Adaptive selection of an incretin gene in Eurasian populations
- (2010) C. L. Chang et al. GENOME RESEARCH
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
- (2010) Elizabeth K Speliotes et al. NATURE GENETICS
- Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
- (2010) Richa Saxena et al. NATURE GENETICS
- Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8 and IGF1 Are Associated with Glucose Metabolism in the Chinese
- (2010) Cheng Hu et al. PLoS One
- GIP and GLP-1, the two incretin hormones: Similarities and differences
- (2010) Yutaka Seino et al. Journal of Diabetes Investigation
- Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
- (2010) Daisuke Yabe et al. Journal of Diabetes Investigation
- Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
- (2009) K. Mussig et al. DIABETES
- A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion
- (2009) S. A. Schäfer et al. DIABETOLOGIA
- Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
- (2009) Luan Shu et al. HUMAN MOLECULAR GENETICS
- Diabetes in Asia
- (2009) Juliana C. N. Chan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hyperglycemia Acutely Lowers the Postprandial Excursions of Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide in Humans
- (2009) Kirsten Vollmer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- Pharmacokinetics and Pharmacodynamics of Vildagliptin in Healthy Chinese Volunteers
- (2008) Pei Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
- (2008) Kazuki Yasuda et al. NATURE GENETICS
- SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
- (2008) Hiroyuki Unoki et al. NATURE GENETICS
- Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension
- (2008) R. Huxley et al. Obesity Reviews
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now